Phase II trial PD-L1/PD-1 blockade avelumab with chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer: The Ave-Rec trial.
暂无分享，去创建一个
N. Pavlakis | J. Tie | D. Goldstein | J. Zalcberg | R. Ramsay | M. Michael | A. Heriot | R. Wong | S. Ngan | P. Neeson | C. Mitchell | E. Segelov | M. Farrell | E. Link | K. Wilson | S. Gill